Abstract
Surgical therapy (clipping) and endovascular therapy (coiling) are the main treatment options for people with cerebral aneurysms. In recent years, minimally invasive coil embolization has been recommended. However, the surgical method presents challenges in terms of the filling rate and operability, thus highlighting the need for a novel embolization material. In this study, injectable inclusion complexes for cerebral aneurysm treatment were prepared by α-cyclodextrin (α-CD) and hydrophobically modified poly(vinyl alcohol) (hm-PVA) with various alkyl chain lengths (3, 9, and 18). 2D-NMR NOESY spectra indicated that a threaded inclusion complex was formed between α-CD and hm-PVA. By mixing hm-PVAs with different concentrations of α-CD, only hm-PVA (5 mol% nonanal-modified PVA (5C9-PVA)) with 15 mM α-CD showed good thixotropic properties. In addition, this inclusion complex showed gel–sol transition behavior under different strain amplitudes (1 and 1000%). The α-CD/5C9-PVA inclusion complex showed good injectability, even when using a 25 G needle. After injecting the α-CD/5C9-PVA inclusion complex into an in vitro cerebral aneurysm model, it formed aggregates in phosphate buffer solution at 37 °C and filled the whole area. These results demonstrate that the α-CD/5C9-PVA inclusion complex could be an ideal material for cerebral aneurysm treatment.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
van der Schaaf I, Algra A, Wermer M, Molyneux A, Clarke M, van Gijn J, et al. Endovascular coiling versus neurosurgical clipping for patients with aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2005;CD003085.
Zhao L, Zhang L, Zhang X, Li Z, Tian L, Wang Y-XJ. An analysis of 1256 cases of sporadic ruptured cerebral aneurysm in a single Chinese Institution. PLoS ONE. 2014;9:e85668.
Korja M, Kaprio J. Controversies in epidemiology of intracranial aneurysms and SAH. Nat Rev Neurol. 2016;12:50–55.
Petridis AK, Kamp MA, Cornelius JF, Beez T, Beseoglu K, Turowski B, et al. Aneurysmal subarachnoid hemorrhage. Dtsch Arztebl Int. 2017;114:226–36.
Rinkel GJE, Djibuti M, Algra A, van Gijn J. Prevalence and risk of rupture of intracranial aneurysms—a systematic review. Stroke. 1998;29:251–6.
Huh CW, Lee JI, Choi CH, Lee TH, Choi JY, Ko JK. Endosaccular treatment of very large and giant intracranial aneurysms with parent artery preservation: single center experience with long term follow-up. J Korean Neurosurgical Soc. 2018;61:450–7.
Ajiboye N, Chalouhi N, Starke RM, Zanaty M, Bell R. Unruptured cerebral aneurysms: evaluation and management. TheScientificWorldJournal. 2015;2015:954954.
Martin NA. The combination of endovascular and surgical techniques for the treatment of intracranial aneurysms. Neurosurg Clin North Am. 1998;9:897–916.
Ross LB, Weill A, Piotin M, Moret J. Endovascular treatment of distally located giant aneurysms. Neurosurgery. 2000;47:1147–52.
Guglielmi G. History of the genesis of detachable coils a review. J Neurosurg. 2009;111:1–8.
Canton G, Levy DI, Lasheras JC. Changes in the intraaneurysmal pressure due to HydroCoil embolization. Am J Neuroradiol. 2005;26:904–7.
Kang HS, Han MH, Kwon BJ, Kwon OK, Kim SH, Choi SH, et al. Short-term outcome of intracranial aneurysms treated with polyglycolic acid/lactide copolymer-coated coils compared to historical controls treated with bare platinum coils: a single-center experience. Am J Neuroradiol. 2005;26:1921–8.
Molyneux AJ, Cekirge S, Saatci I, Gal G. Cerebral Aneurysm Multicenter European Onyx (CAMEO) trial: results of a prospective observational study in 20 European centers. Am J Neuroradiol. 2004;25:39–51.
Kurdi M, Baeesa S, Bin-Mahfoodh M, Kurdi K. Onyx embolization of ruptured intracranial aneurysm associated with Behcet’s Disease. Case Rep. Vasc Med. 2013;2013:797045.
Hamada JI, Kai Y, Mizuno T, Morioka M, Kazekawa K, Iwata H, et al. A nonadhesive liquid embolic agent of ethylene vinyl alcohol copolymer and ethanol mixture for cerebral arteriovenous malformations—clinical experience. Interventional Neuroradiol. 2004;10:135–42.
Chen X, Taguchi T. Hydrophobically modified poly(vinyl alcohol)s as antithrombogenic coating materials. Mater Sci Eng C. 2019;102:289–98.
Chen X, Taguchi T. Injectable, non-diffusible, and pre-filled bone paste composed of α-tricalcium phosphate and hydrophobically modified poly(vinyl alcohol). Adv Eng Mater. 2019;21:1900660.
Mansur HS, Sadahira CM, Souza AN, Mansur AAP. FTIR spectroscopy characterization of poly (vinyl alcohol) hydrogel with different hydrolysis degree and chemically crosslinked with glutaraldehyde. Mater Sci Eng C. 2008;28:539–48.
Tomihata K, Ikada Y. Crosslinking of hyaluronic acid with glutaraldehyde. J Polym Sci Pol Chem. 1997;35:3553–9.
Hao X, Xu M, Hu J, Yan Q. Photoswitchable thermogelling systems based on a host-guest approach. J Mater Chem C. 2017;5:10549–54.
Li Q, Barret DG, Messersmith PB, Holten-Andersen N. Controlling hydrogel mechanics via bio-inspired polymer-nanoparticle bond dynamics. Acs Nano. 2016;10:1317–24.
Yuece C, Willenbacher N. Challenges in rheological characterization of highly concentrated suspensions—a case study for screen-printing silver pastes. J Vis Exp. 2017;e55377.
Montufar EB, Traykova T, Schacht E, Ambrosio L, Santin M, Planell JA, et al. Self-hardening calcium deficient hydroxyapatite/gelatine foams for bone regeneration. J Mater Sci Mater Med. 2010;21:863–9.
Chen MH, Wang LL, Chung JJ, Kim Y-H, Atluri P, Burdick JA. Methods to assess shear-thinning hydrogels for application as injectable biomaterials. Acs Biomater Sci Eng. 2017;3:3146–60.
Sivashanmugam A, Charoenlarp P, Deepthi S, Rajendran A, Nair SV, Iseki S, et al. Injectable shear-thinning CaSO4/FGF-18-incorporated chitin PLGA hydrogel enhances bone regeneration in mice cranial bone defect model. Acs Appl Mater Interfaces. 2017;9:42639–52.
Tomatsu I, Hashidzume A, Harada A. Photoresponsive hydrogel system using molecular recognition of alpha-cyclodextrin. Macromolecules. 2005;38:5223–7.
Jara P, Barrientos L, Herrera B, Sobrados I. Inclusion compounds of alpha-cyclodextrin with alkylthiols. J Chil Chem Soc. 2008;53:1474–6.
Chhabra RP. Non-newtonian fluids: an introduction. Rheology of Complex Fluids. 2010.p:3–34.
Acknowledgements
We acknowledge Dr A. Nishiguchi, Mrs M. Katano, Mrs S. Watanabe, and Mrs Y. Kurihara from the Polymeric Biomaterials Group at the National Institute for Materials Science (NIMS) for their technical support. This research was partially supported by the Project for Japan Translational and Clinical Research Core Centers from the Japan Agency for Medical Research and Development (AMED), “Innovation Inspired by Nature” Research Support Program, SEKISUI CHEMICAL CO. LTD, and the Uehara Memorial Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Chen, X., Taguchi, T. Injectable inclusion complex composed of α-cyclodextrin and hydrophobically modified poly(vinyl alcohol) as a cerebral aneurysm embolization material. Polym J 52, 793–802 (2020). https://doi.org/10.1038/s41428-020-0321-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41428-020-0321-1